Takeda Pharmaceutical Company Limited
TKPHF
$28.35
$0.672.42%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.57B | 3.14B | 6.00B | 5.00B | 3.03B |
Total Receivables | 4.84B | 4.68B | 5.03B | 4.80B | 4.61B |
Inventory | 8.13B | 7.93B | 8.42B | 7.94B | 8.00B |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.29B | 1.77B | 1.87B | 1.58B | 1.28B |
Total Current Assets | 16.84B | 17.52B | 21.32B | 19.32B | 16.92B |
|
|||||
Total Current Assets | 16.84B | 17.52B | 21.32B | 19.32B | 16.92B |
Net Property, Plant & Equipment | 13.14B | 12.83B | 13.18B | 12.96B | 13.16B |
Long-term Investments | 35.56B | 35.12B | 36.02B | 35.64B | 35.77B |
Goodwill | 35.56B | 35.12B | 36.02B | 35.64B | 35.77B |
Total Other Intangibles | 24.25B | 25.14B | 26.32B | 27.14B | 28.26B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.29B | 5.39B | 4.78B | 5.27B | 5.20B |
Total Assets | 95.15B | 96.09B | 101.72B | 100.88B | 99.89B |
|
|||||
Total Accounts Payable | 2.06B | 2.93B | 2.89B | 2.91B | 2.12B |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 2.30B | -- | -- | 1.86B | 2.10B |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.79B | 861.64M | 4.36B | 862.48M | 768.29M |
Total Finance Division Other Current Liabilities | 10.58B | 9.56B | 9.42B | 9.68B | 10.31B |
Total Other Current Liabilities | 10.58B | 9.56B | 9.42B | 9.68B | 10.31B |
Total Current Liabilities | 16.74B | 13.34B | 16.66B | 15.32B | 15.29B |
|
|||||
Total Current Liabilities | 16.74B | 13.34B | 16.66B | 15.32B | 15.29B |
Long-Term Debt | 26.49B | 29.92B | 30.90B | 31.34B | 29.60B |
Short-term Debt | 2.30B | -- | -- | 1.86B | 2.10B |
Capital Leases | 3.40B | 3.76B | 3.90B | 3.83B | 3.66B |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 2.21B | 1.87B | 1.95B | 1.89B | 3.25B |
Total Liabilities | 48.83B | 48.90B | 53.41B | 52.39B | 51.80B |
|
|||||
Common Stock & APIC | 23.17B | 21.95B | 23.96B | 21.36B | 22.64B |
Retained Earnings | 7.93B | 8.21B | 9.99B | 8.32B | 9.20B |
Treasury Stock & Other | 15.21B | 17.02B | 14.35B | 18.80B | 16.25B |
Total Common Equity | 46.31B | 47.18B | 48.31B | 48.48B | 48.09B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 46.31B | 47.18B | 48.31B | 48.48B | 48.09B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 5.98M | 5.83M | 5.88M | 5.07M | 4.90M |
Total Equity | 46.32B | 47.19B | 48.31B | 48.48B | 48.09B |
|